0001997658-23-000001.txt : 20231017 0001997658-23-000001.hdr.sgml : 20231017 20231017143940 ACCESSION NUMBER: 0001997658-23-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20231017 DATE AS OF CHANGE: 20231017 EFFECTIVENESS DATE: 20231017 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Novastream Therapeutics Inc. CENTRAL INDEX KEY: 0001997658 IRS NUMBER: 871530843 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-495011 FILM NUMBER: 231329394 BUSINESS ADDRESS: STREET 1: 5595 WASHINGTON STREET CITY: DENVER STATE: CO ZIP: 80216 BUSINESS PHONE: 720-924-9237 MAIL ADDRESS: STREET 1: 5595 WASHINGTON STREET CITY: DENVER STATE: CO ZIP: 80216 D 1 primary_doc.xml X0708 D LIVE 0001997658 Novastream Therapeutics Inc. 5595 WASHINGTON STREET DENVER CO COLORADO 80216 720-924-9237 DELAWARE None None Corporation true 2021 Manuel Ornelas c/o Novastream Therapeutics Inc. 5595 Washington Street Denver CO COLORADO 80216 Executive Officer Director Jason Novak c/o Novastream Therapeutics Inc. 5595 Washington Street Denver CO COLORADO 80216 Director Mark Webb c/o Novastream Therapeutics Inc. 5595 Washington Street Denver CO COLORADO 80216 Director Thomas Kluz c/o Novastream Therapeutics Inc. 5595 Washington Street Denver CO COLORADO 80216 Director Biotechnology Not Applicable 06b false 2023-10-03 false true true SAFE false 0 250000 50000 200000 false 4 0 0 0 false Novastream Therapeutics Inc. /s/ Manuel Ornelas Manuel Ornelas President 2023-10-17